Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to revaluate funding for Myeloma (a) care and (b) research under the NHS Long Term Plan.

NHS England has committed funding of over £1.3 billion over the next five years to deliver the commitments on cancer in the NHS Long Term Plan. These commitments include:

- Speeding up the path from innovation to business-as-usual, spreading proven new techniques and technologies and reducing variation; and

- By 2021, where appropriate every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support.

In September 2019 we announced funding of £200 million for new equipment to drive earlier diagnosis of cancer and improve survival. More than 300 diagnostic machines will be funded across the country, replacing outdated MRI machines, CT scans and breast screening equipment with cutting edge technology. The new machines will be “AI-enabled” to keep pace with future advances in technology

Research is crucial in the fight against cancer. That is why the Department invests £1billion per year in health research through the National Institute for Health Research (NIHR). In 2017/18 NIHR cancer research expenditure was £136 million, which constitutes the largest investment in a disease area.